Hair Loss News

Navigation

Hair Loss News Archives


July 2010


Dr Alan Bauman of Bauman Medical Group Offers Expertise During National Hair Loss Awareness Month


Over 100 million Americans are affected – including 60 million men and 40 million women.

July 2010

Renowned authority on hair loss, Dr. Alan Bauman (M.D.), is available to interview on this subject. He is a board-certified hair restoration surgeon and provides the latest cutting-edge treatments at his South Florida clinic. He has previously appeared on Today, The Early Show, Good Morning America, CNN, Men’s Health, Cosmo, Vogue, BBC, etc.

Hair loss can be medically treated. Treatments range from FDA-approved medications to “laser combs” and new no-scalpel, no-stitch minimally invasive surgery. These options exist for both men and women, young and old.

The public education campaign of the American Academy of Dermatology (www.aad.org) is designed to raise awareness of the signs and symptoms of hereditary hair loss and the effective treatments and procedures available. This year, the 10th Anniversary of the Annual Hair Loss Awareness Month, holds special meaning for the estimated 60 million men and 40 million women in the U.S. who suffer from thinning or receding hair, as hair restoration therapies continue to improve.

Members of the International Society of Hair Restoration Surgery (www.ishrs.org) are now more adept than ever at helping their patients achieve their hair restoration goals using a combination of effective invasive and non-invasive therapies.

With the success of thousands of patients under his belt and having logged hundreds of hours of broadcast media experience, Dr. Bauman is an excellent source of expert medical commentary, is highly quotable and understands the needs and demands of the print, radio and broadcast media.

“Hereditary hair loss can cause significant distress in women as well as men, so it's important for patients to get accurate information about this medically-treatable condition from a board-certified hair restoration physician before 'panic' sets in," Dr. Bauman said. "New genetic tests can alert concerned consumers to the need for effective preventative treatments, and exciting advances in minimally-invasive hair transplants can help to restore hair if it's already gone."

According to Dr. Bauman, here are the top treatments and tests available for hair loss:

NEW -- Follicular Unit Extraction (FUE) hair transplants using the NeoGraft™ device – Unlike outdated 'hair plugs' or strip-harvesting, a new machine-assisted minimally-invasive hair transplant procedure allows both men and women to permanently and undetectably restore lost hair with less recovery time and less discomfort than traditional procedures. The revolutionary NeoGraft™ device allows surgeons to efficiently harvest follicles individually from the back of the scalp, leaving no linear scar.
NEW -- LaserCap™ for laser hair therapy – A breakthrough device which delivers ‘clinical-grade’ low level laser therapy in a convenient, at-Hair Loss device. Cordless and rechargeable, the 224 diode LaserCap fits discreetly under a baseball hat for hands-free hair growth treatment. Two similar laser devices have achieved FDA-clearance for hair growth and dozens are available on the market for cosmetic use.
NEW -- HairCheck™ for hair loss/hair regrowth tracking and analysis in minutes – Is your treatment working? The non-invasive HairCheck™ device allows for a quick, reliable, repeatable and scientifically-proven way to measure Hair Mass Index (HairNumber), an indicator of how much hair is growing from a given area of scalp for comparison over time. Also accurately measures hair-breakage, a common cause of hair loss in women.
NEW -- Genetic Tests for Hair Loss and Finasteride Response – The first genetic test to predict future hair loss is now available for men and women from hair restoration physicians. A simple, non-invasive cheek-swab can accurately predict an individual's risk for significant baldness before signs and symptoms are severe, which also happens to be the best time to initiate therapy. The Finasteride Response Test can accurately predict how well a man will respond to treatment with finasteride (the active ingredient in Merck's Propecia™) to prevent hair loss.
FDA Approved Medications – The oral medication finasteride (i.e., Propecia) and the topical solution minoxidil (i.e., Rogaine) are the only medications approved by the FDA for male pattern hair loss. Additionally, Rogaine is approved for female pattern hair loss.
For more information about these hair loss treatments and tests, visit Dr. Bauman's website at www.baumanmedical.com.

About Dr. Alan Bauman

Alan Bauman, M.D., founder of Bauman Medical Group in Boca Raton, Florida, is an internationally renowned and board-certified hair transplant surgeon. He is a featured lecturer at major medical conferences and doctors’ workshops all over the world. Dr. Bauman is regularly consulted by national news media organizations, and has been featured in Newsweek, The New York Times, Cosmo, Vogue, Allure, Men's Health, Today, The Early Show, Good Morning America, Extra, Access Hollywood, and Dateline NBC.